Skip to main content
OpenTrials
Completed

NCT Number: NCT02733003

Implementation Research for Vulnerable Women in South Africa

This study sought to implement the Women's Health CoOp (Cooperative) (WHC) intervention into healthcare, antenatal, and substance treatment clinics in South Africa and translated this evidence-based intervention into real-world settings. Implementation, service, and patient outcomes will be evaluated through an iterative stepped wedge design.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Kheth'Impilo, Cape Town, South Africa

Loading trial locations.

About this study

This five-year implementation science study used a cluster-randomized stepped-wedge design to evaluate the implementation, service, and patient outcomes associated with the WHC for alcohol and other drug (AOD)-using HIV positive women in usual care settings.

A list of four substance use treatment clinics and four healthcare clinics, identified and approved by the City of Cape Town, South Africa were randomized to begin the intervention during one of the four cycles. Each healthcare clinic was paired with a substance use treatment clinic based on geographic proximity, and each pair was randomized by computer into four succeeding 6-month implementation cycles where implementation of the WHC took place simultaneously at the paired sites. Approximately 120 HIV positive participants were recruited in each cycle (approximately 60 from each clinic) for the patient level outcomes.

Both qualitative and quantitative data were collected to assess the appropriateness of marketing plans developed through formative methods, as well as the acceptability, adoption, feasibility, fidelity, and sustainability of the WHC intervention implementation as well as service outcomes (comprehensive services and timely service linkages) during each implementation cycle.

Each implementation cycle included a pre-implementation period, implementation period (6-months), and post-implementation period. In the pre-implementation period, focus groups and questionnaires surveys were conducted with clinic staff to assess the readiness of each site to implement the WHC. During the implementation period, employees at each site were trained to facilitate the WHC and the WHC was integrated into site operations. Subsequently, in the post-implementation period the researchers collected data related to challenges, benefits, and sustainability from each site. The process was repeated for each cycle and these formative periods between cycles were used to inform backward- and forward- implementation strategies, make modifications to the WHC, and leave time for site-specific training for the next cycle. Consequently, the sites randomized to the first cycle had the longest post-intervention observation period whose implementation sustainability was checked through fidelity forms and sustainability questionnaires, and sites in the fourth cycle benefited the most because of lessons learned and information shared from previous cycles.

The intervention was implemented in a group, however there were instances when only one participant was available and therefore the intervention was implemented one-on-one. The WHC has previously been tested in group and one-on-one formats and both have demonstrated consistent significant intervention effects. Research staff trained clinic staff members to deliver the intervention. The intervention was delivered by clinic staff and was not part of the research. The research questions were related to the feasibility of implementing the intervention in clinics and its acceptability to clinic staff and patients. The researchers collected information on patient-level outcomes to determine if the intervention was effective when it was delivered by clinic staff to patients in the clinic. Also, to assess acceptability of the intervention workshops among patients, the researchers conducted post-implementation focus groups with a randomly selected sub-sample of participants who participated in the intervention and completed their final 6-month appointment in each implementation cycle.

Implementation of the WHC in usual care settings has the potential to reach more vulnerable women and could have a high public health impact if implementation is shown to be effective and sustainable in these real-world settings.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Clinic Inclusion Criteria:

  • HIV/antenatal clinic or substance abuse treatment clinic
  • Located in townships surrounding Cape Town
  • Willing to take part in study

Patient Inclusion Criteria:

  • Female;
  • 18 to 45 years of age;
  • Reports use of at least one drug, including alcohol, at least weekly during the previous 3 months;
  • Reports unprotected sex with a male partner in the past 6 months;
  • Has a positive HIV test result from either the participating health clinic or rehab clinic, or a clinic issued ARV card or ARV medication as proof of positive status;
  • Reports the intention to remain in the area for at least the next 6 months;
  • Provides informed consent to participate.

Patient Exclusion Criteria:

  • Not HIV Positive
  • Not willing to do alcohol and drug screening

Treatment and study plan

Women's Health CoOp (WHC)

Behavioral

Participants in this group will participate in two workshops of the woman-focused intervention about HIV/STIs, sexual behaviors, alcohol and other drug use, violence, communication skills, and other issues.

Primary outcomes

  1. Implementation and Service Outcomes: Readiness for appropriate change (appropriateness)

    Time frame: Baseline

    Explore perceived appropriateness of implementing the intervention through qualitative focus groups with clinic staff and patients

  2. Implementation and Service Outcomes: Readiness for appropriate change (appropriateness)

    Time frame: 6-months post-enrollment

    Explore perceived appropriateness of implementing the intervention through qualitative focus groups with clinic staff and patients

  3. Implementation and Service Outcomes: Readiness for appropriate change (appropriateness)

    Time frame: Baseline

    Explore perceived appropriateness of implementing the intervention through clinic staff survey

  4. Implementation and Service Outcomes: Acceptability of the Women's Health CoOp (WHC) intervention

    Time frame: Baseline

    Assess perceived acceptability through qualitative focus groups with clinic staff and patients

  5. Implementation and Service Outcomes: Acceptability of the Women's Health CoOp (WHC) intervention

    Time frame: 6-months post-enrollment

    Assess perceived acceptability through qualitative focus groups with clinic staff and patients

  6. Implementation and Service Outcomes: Acceptability of the Women's Health CoOp (WHC) intervention

    Time frame: Baseline

    Assess perceived acceptability through patient interviews

  7. Implementation and Service Outcomes: Acceptability of the Women's Health CoOp (WHC) intervention

    Time frame: 6-months post-enrollment

    Assess perceived acceptability through patient interviews

  8. Implementation and Service Outcomes: Acceptability of the Women's Health CoOp (WHC) intervention

    Time frame: Baseline

    Assess perceived acceptability through clinic staff survey

  9. Implementation and Service Outcome: Adoption of the Women's Health CoOp (WHC) intervention

    Time frame: Baseline

    Assess adoption of the intervention through qualitative focus groups with clinic staff.

  10. Implementation and Service Outcome: Adoption of the WHC intervention

    Time frame: 6-months post-enrollment

    Assess adoption of the intervention through qualitative focus groups with clinic staff.

  11. Implementation and Service Outcome: Cost

    Time frame: Baseline

    Assess start up and ongoing implementation costs

  12. Implementation and Service Outcome: Cost

    Time frame: 6-months post-enrollment

    Assess start up and ongoing implementation costs

  13. Implementation and Service Outcome: Feasibility

    Time frame: Throughout the period of the study, up to a maximum of one year

    Exposure as measured by the ratio of the number of intervention workshops delivered to participants (a total of two across the intervention window) (compared to the total expected intervention visits. Acceptable retention measured at ≥85% of patients who complete both workshops within the intervention window.

  14. Implementation and Service Outcome: Fidelity

    Time frame: Throughout the study at bimonthly intervals for up to one year

    Observation: fidelity item scores where a 90% or above fidelity rating will indicate acceptable fidelity

  15. Implementation and Service Outcomes: Sustainability

    Time frame: Throughout the period of the study, up to a maximum of one year

    Examine sustainability through qualitative focus groups with clinic staff

  16. Implementation and Service Outcomes: Sustainability

    Time frame: 6 months post-intervention

    Examine sustainability with clinic staff using an adapted TCU Workshop Assessment Follow-up Scale

Secondary outcomes

  1. Antiretroviral Therapy (ART) Initiation and Adherence

    Time frame: Baseline

    Number of participants that received clinical staging, were prescribed and initiated on antiretroviral therapy (ART) and were adhering to ART.

  2. Antiretroviral Therapy (ART) Initiation and Adherence

    Time frame: 6 months post-enrollment

    Number of participants that received clinical staging, were prescribed and initiated on antiretroviral therapy (ART) and were adhering to ART.

  3. Alcohol Use - self-reported frequency and amount

    Time frame: Baseline

    Participants' self-reported frequency and amount of alcohol use will be used to assess recent alcohol use.

  4. Alcohol Use - self-reported frequency and amount

    Time frame: 6 months post-enrollment

    Participants' self-reported frequency and amount of alcohol use will be used to assess recent alcohol use.

  5. Alcohol Use

    Time frame: Baseline

    Breathalyzer test results will be used to assess recent alcohol use.

  6. Alcohol Use

    Time frame: 6 months post-enrollment

    Breathalyzer test results will be used to assess recent alcohol use.

  7. Substance Use

    Time frame: Baseline

    Participants' frequency of benzodiazepines, cocaine, methamphetamine, MDMA, marijuana, and/or mandrax use will be used to assess recent substance use.

  8. Substance Use

    Time frame: 6-months post-enrollment

    Participants' frequency of benzodiazepines, cocaine, methamphetamine, MDMA, marijuana, and/or mandrax use will be used to assess recent substance use.

  9. Substance use

    Time frame: Baseline

    Urine drug screen test results will be used to assess recent use of drugs (benzodiazepines, cocaine, methamphetamine, MDMA, marijuana, and/or mandrax).

  10. Substance use

    Time frame: 6-months post-enrollment

    Urine drug screen test results will be used to assess recent use of drugs (benzodiazepines, cocaine, methamphetamine, MDMA, marijuana, and/or mandrax).

  11. Sexual Risk

    Time frame: Baseline

    Participants' self-reported frequency of condom use.

  12. Sexual Risk

    Time frame: 6-months post-enrollment

    Participants' self-reported frequency of condom use.

  13. Sexual Risk

    Time frame: Baseline

    Participants' self-reported number of sex partners.

  14. Sexual Risk

    Time frame: 6-months post-enrollment

    Participants' self-reported number of sex partners.

  15. Violence/Victimization

    Time frame: Baseline

    Percentages of participants who report being beaten, attacked with a weapon, or forced to have sex.

  16. Violence/Victimization

    Time frame: 6-months post-enrollment

    Percentages of participants who report being beaten, attacked with a weapon, or forced to have sex.

  17. Sexual Communication

    Time frame: Baseline

    The extent to which women have the skills to discuss sexual topics with their partners

  18. Sexual Communication

    Time frame: 6-months post-enrollment

    The extent to which women have the skills to discuss sexual topics with their partners

  19. Relationship Power

    Time frame: Baseline

    The extent to which women and their partners can equitably make decisions together as measured by the Relationship Power Scale (RPS)

  20. Relationship Power

    Time frame: 6-months post-enrollment

    The extent to which women and their partners can equitably make decisions together as measured by the Relationship Power Scale (RPS)

Sponsors and collaborators

Lead sponsor

RTI International

Other

Collaborators

  • Kheth'Impilo

Registry information

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Apr 11, 2016
Registry last updated
Jan 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.